
Cambridge Nutritional Sciences PLC
LSE:CNSL

Operating Margin
Cambridge Nutritional Sciences PLC
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
UK |
![]() |
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
6.8m GBP |
-3%
|
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.2T JPY |
29%
|
|
CH |
![]() |
Alcon AG
SIX:ALC
|
35.1B CHF |
14%
|
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
141.9B DKK |
27%
|
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD |
17%
|
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP |
15%
|
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.5B CNY |
43%
|
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF |
14%
|
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.6B USD |
12%
|
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD |
29%
|
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7T KRW |
-149%
|
Cambridge Nutritional Sciences PLC
Glance View
Cambridge Nutritional Sciences Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The firm develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The firm serves healthcare professionals and the consumer directly with a focus on health and nutrition products.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Cambridge Nutritional Sciences PLC's most recent financial statements, the company has Operating Margin of -3.3%.